G-quadruplex DNA aptamers and their ligands: Structure, function and application

Current Pharmaceutical Design

Volumn 18, Issue 14, 2012, Pages 2014-2026

  Tucker, W O ^a   Shum, K T ^a   Tanner, J A ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Aptamer; G quadruplex; G quartet; G4 tetrad; Sclerostin; SELEX; Thrombin

Indexed keywords

ACT GRO 777; ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; APTAMER; AS1411; DNA; GLYCOPROTEIN GP 120; GUANINE QUADRUPLEX; HEMATOPORPHYRIN; HEMIN; INSULIN; INTEGRASE; LIGAND; MOLECULAR SCAFFOLD; NUCLEOCAPSID PROTEIN; OCHRATOXIN; POTASSIUM ION; PROTEIN TYROSINE PHOSPHATASE SHP 2; RIBONUCLEASE; RNA DIRECTED RNA POLYMERASE; SCLEROSTIN; STAT PROTEIN; THROMBIN; UNCLASSIFIED DRUG; ZIDOVUDINE;

BIOCHEMISTRY; BLOOD CLOTTING DISORDER; BONE DISEASE; COMBINATORIAL CHEMISTRY; DIAGNOSTIC PROCEDURE; DNA BINDING; DNA STRUCTURE; ELECTROSPRAY; ENZYME BINDING; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IC 50; KIDNEY CARCINOMA; MOLECULAR RECOGNITION; MYELOID LEUKEMIA; NEOPLASM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RAMAN SPECTROMETRY; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 84860122883     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212799958477     Document Type: Review

References (149)

1. Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature 1990; 346: 818-822.
2. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990; 249: 505-510.
3. Ellington AD, Szostak JW. Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures. Nature 1992; 355: 850-852.
4. Breaker RR, Joyce GF. A DNA enzyme that cleaves RNA. Chem Biol 1994; 1: 223-229.
5. Wang KY, McCurdy S, Shea RG, Swaminathan S, Bolton PH. A DNA aptamer which binds to and inhibits thrombin exhibits a new structural motif for DNA. Biochemistry 1993; 32: 1899-1904.
6. Wang KY, Krawczyk SH, Bischofberger N, Swaminathan S, Bolton PH. The tertiary structure of a DNA aptamer which binds to and inhibits thrombin determines activity. Biochemistry 1993; 32: 11285-11292.
7. Padmanabhan K, Padmanabhan KP, Ferrara JD, Sadler JE, Tulinsky A. The structure of alpha-thrombin inhibited by a 15-mer single-stranded DNA aptamer. J Biol Chem 1993; 268: 17651-17654.
8. Kikin O, D'Antonio L, Bagga PS. QGRS Mapper: a web-based server for predicting G-quadruplexes in nucleotide sequences. Nucleic Acids Res 2006; 34: W676-W682.
9. Ji X, Sun H, Zhou H, Xiang J, Tang Y, Zhao C. Research progress of RNA quadruplex. Nucl Acid Ther 2011; 21: 185-200.
10. Sissi C, Gatto B, Palumbo M. The evolving world of protein-G-quadruplex recognition: a medicinal chemist's perspective. Biochimie 2011; 93: 1219-1230.
11. Gatto B, Palumbo M, Sissi C. Nucleic acid aptamers based on the G-quadruplex structure: therapeutic and diagnostic potential. Curr Med Chem 2009; 16: 1248-1265.
12. Shum KT, Chan C, Leung CM, Tanner JA. Identification of a DNA aptamer that inhibits sclerostin's antagonistic effect on Wnt signalling. Biochem J 2011; 434: 493-501.
13. Shum KT, Lui EL, Wong SC, et al. Aptamer-mediated inhibition of Mycobacterium tuberculosis polyphosphate kinase 2. Biochemistry 2011; 50: 3261-3271.
14. Shum KT, Tanner JA. Differential inhibitory activities and stabilisation of DNA aptamers against the SARS coronavirus helicase. Chembiochem 2008; 9: 3037-3045.
15. Bock LC, Griffin LC, Latham JA, Vermaas EH, Toole JJ. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 1992; 355: 564-566.
16. Ireson CR, Kelland LR. Discovery and development of anticancer aptamers. Mol Cancer Ther 2006; 5: 2957-2962.
17. Zhu Q, Jing N. Computational study on mechanism of G-quartet oligonucleotide T40214 selectively targeting Stat3. J Comput Aided Mol Des 2007; 21: 641-648.
18. Weerasinghe P, Garcia GE, Zhu Q, et al. Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides. Int J Oncol 2007; 31: 129-136.
19. Pileur F, Andreola ML, Dausse E, et al. Selective inhibitory DNA aptamers of the human RNase H1. Nucleic Acids Res 2003; 31: 5776-5788.
20. Hu J, Wu J, Li C, et al. A G-quadruplex aptamer inhibits the phosphatase activity of oncogenic protein Shp2 in vitro. Chembiochem 2011; 12: 424-430.
21. Nonaka Y, Sode K, Ikebukuro K. Screening and improvement of an anti-VEGF DNA aptamer. Molecules 2010; 15: 215-225.
22. Wyatt JR, Vickers TA, Roberson JL, et al. Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion. Proc Natl Acad Sci USA 1994; 91: 1356-1360.
23. Hotoda H, Koizumi M, Koga R, et al. Biologically active oligodeoxyribonucleotides. 5. 5'-End-substituted d(TGGGAG) possesses anti-human immunodeficiency virus type 1 activity by forming a G-quadruplex structure. J Med Chem 1998; 41: 3655-3663.
24. Phan AT, Kuryavyi V, Ma JB, Faure A, Andreola ML, Patel DJ. An interlocked dimeric parallel-stranded DNA quadruplex: a potent inhibitor of HIV-1 integrase. Proc Natl Acad Sci USA 2005; 102: 634-639.
25. Andreola ML, Pileur F, Calmels C, Ventura M, Tarrago-Litvak L, Toulme JJ, Litvak S. DNA aptamers selected against the HIV-1 RNase H display in vitro antiviral activity. Biochemistry 2001; 40: 10087-10094.
26. Michalowski D, Chitima-Matsiga R, Held DM, Burke DH. Novel bimodular DNA aptamers with guanosine quadruplexes inhibit phylogenetically diverse HIV-1 reverse transcriptases. Nucleic Acids Res 2008; 36: 7124-7135.
27. Kankia BI, Barany G, Musier-Forsyth K. Unfolding of DNA quadruplexes induced by HIV-1 nucleocapsid protein. Nucleic Acids Res 2005; 33: 4395-4403.
28. Jones LA, Clancy LE, Rawlinson WD, White PA. High-affinity aptamers to subtype 3a hepatitis C virus polymerase display genotypic specificity. Antimicrob Agents Chemother 2006; 50: 3019-3027.
29. Yoshida W, Mochizuki E, Takase M, et al. Selection of DNA aptamers against insulin and construction of an aptameric enzyme subunit for insulin sensing. Biosens Bioelectron 2009; 24: 1116-1120.
30. Okazawa A, Maeda H, Fukusaki E, Katakura Y, Kobayashi A. In vitro selection of hematoporphyrin binding DNA aptamers. Bioorg Med Chem Lett 2000; 10: 2653-2656.
31. Li Y, Geyer CR, Sen D. Recognition of anionic porphyrins by DNA aptamers. Biochemistry 1996; 35: 6911-6922.
32. Travascio P, Li Y, Sen D. DNA-enhanced peroxidase activity of a DNA-aptamer-hemin complex. Chem Biol 1998; 5: 505-517.
33. Cruz-Aguado JA, Penner G. Determination of ochratoxin a with a DNA aptamer. J Agric Food Chem 2008; 56: 10456-10461.
34. Ueyama H, Takagi M, Takenaka S.A novel potassium sensing in aqueous media with a synthetic oligonucleotide derivative. Fluorescence resonance energy transfer associated with Guanine quartet-potassium ion complex formation. J Am Chem Soc 2002; 124: 14286-14287.
35. Huizenga DE, Szostak JW. A DNA aptamer that binds adenosine and ATP. Biochemistry 1995; 34: 656-665.
36. Williamson JR, Raghuraman MK, Cech TR. Monovalent cation-induced structure of telomeric DNA: the G-quartet model. Cell 1989; 59: 871-880.
37. Lane AN, Chaires JB, Gray RD, Trent JO. Stability and kinetics of G-quadruplex structures. Nucleic Acids Res 2008; 36: 5482-5515.
38. Ji X, Sun H, Zhou H, Xiang J, Tang Y, Zhao C. Research Progress of RNA Quadruplex. Oligonucleotides 2011.
39. Weisman-Shomer P, Fry M. QUAD, a protein from hepatocyte chromatin that binds selectively to guanine-rich quadruplex DNA. J Biol Chem 1993; 268: 3306-3312.
40. Hardin CC, Perry AG, White K. Thermodynamic and kinetic characterization of the dissociation and assembly of quadruplex nucleic acids. Biopolymers 2000; 56: 147-194.
41. Pasternak A, Hernandez FJ, Rasmussen LM, Vester B, Wengel J. Improved thrombin binding aptamer by incorporation of a single unlocked nucleic acid monomer. Nucleic Acids Res 2011; 39: 1155-1164.
42. Kelly JA, Feigon J, Yeates TO. Reconciliation of the X-ray and NMR structures of the thrombin-binding aptamer d(GGTTGGTGTGGTTGG). J Mol Biol 1996; 256: 417-422.
43. Padmanabhan K, Tulinsky A. An ambiguous structure of a DNA 15-mer thrombin complex. Acta Crystallogr D Biol Crystallogr 1996; 52: 272-282.
44. Fialova M, Kypr J, Vorlickova M. The thrombin binding aptamer GGTTGGTGTGGTTGG forms a bimolecular guanine tetraplex. Biochem Biophys Res Commun 2006; 344: 50-54.
45. Paborsky LR, McCurdy SN, Griffin LC, Toole JJ, Leung LL. The single-stranded DNA aptamer-binding site of human thrombin. J Biol Chem 1993; 268: 20808-20811.
46. Macaya RF, Schultze P, Smith FW, Roe JA, Feigon J. Thrombin-binding DNA aptamer forms a unimolecular quadruplex structure in solution. Proc Natl Acad Sci USA 1993; 90: 3745-3749.
47. Schultze P, Macaya RF, Feigon J. Three-dimensional solution structure of the thrombin-binding DNA aptamer d(GGTTGGTGTGGTTGG). J Mol Biol 1994; 235: 1532-1547.
48. Smirnov I, Shafer RH. Effect of loop sequence and size on DNA aptamer stability. Biochemistry 2000; 39: 1462-1468.
49. Marathias VM, Bolton PH. Structures of the potassium-saturated, 2:1, and intermediate, 1:1, forms of a quadruplex DNA. Nucleic Acids Res 2000; 28: 1969-1977.
50. Kuryavyi V, Majumdar A, Shallop A, et al. A double chain reversal loop and two diagonal loops define the architecture of a unimolecular DNA quadruplex containing a pair of stacked G(syn)-G(syn)-G(anti)-G(anti) tetrads flanked by a G-(T-T) Triad and a T-T-T triple. J Mol Biol 2001; 310: 181-194.
51. Mao XA, Gmeiner WH. NMR study of the folding-unfolding mechanism for the thrombin-binding DNA aptamer d(GGTTGGTGTGGTTGG). Biophys Chem 2005; 113: 155-160.
52. Mondragon-Sanchez JA, Liquier J, Shafer RH, Taillandier E. Tetraplex structure formation in the thrombin-binding DNA aptamer by metal cations measured by vibrational spectroscopy. J Biomol Struct Dyn 2004; 22: 365-373.
53. Jayapal P, Mayer G, Heckel A, Wennmohs F. Structure-activity relationships of a caged thrombin binding DNA aptamer: insight gained from molecular dynamics simulation studies. J Struct Biol 2009; 166: 241-250.
54. Mendelboum Raviv S, Horvath A, Aradi J, et al. 4-thio-deoxyuridylate-modified thrombin aptamer and its inhibitory effect on fibrin clot formation, platelet aggregation and thrombus growth on subendothelial matrix. J Thromb Haemost 2008; 6: 1764-71.
55. Nallagatla SR, Heuberger B, Haque A, Switzer C. Combinatorial synthesis of thrombin-binding aptamers containing iso-guanine. J Comb Chem 2009; 11: 364-369.
56. Nagatoishi S, Isono N, Tsumoto K, Sugimoto N. Loop residues of thrombin-binding DNA aptamer impact G-quadruplex stability and thrombin binding. Biochimie 2011.
57. Olsen CM, Lee HT, Marky LA. Unfolding thermodynamics of intramolecular G-quadruplexes: base sequence contributions of the loops. J Phys Chem B 2009; 113: 2587-2595.
58. Sacca B, Lacroix L, Mergny JL. The effect of chemical modifications on the thermal stability of different G-quadruplex-forming oligonucleotides. Nucleic Acids Res 2005; 33: 1182-1192.
59. Pagano B, Martino L, Randazzo A, Giancola C. Stability and binding properties of a modified thrombin binding aptamer. Biophys J 2008; 94: 562-569.
60. Zaitseva M, Kaluzhny D, Shchyolkina A, Borisova O, Smirnov I, Pozmogova G. Conformation and thermostability of oligonucleotide d(GGTTGGTGTGGTTGG)containing thiophosphoryl internucleotide bonds at different positions. Biophys Chem 2010; 146: 1-6.
61. Virno A, Randazzo A, Giancola C, Bucci M, Cirino G, Mayol L. A novel thrombin binding aptamer containing a G-LNA residue. Bioorg Med Chem 2007; 15: 5710-5718.
62. Bonifacio L, Church FC, Jarstfer MB. Effect of locked-nucleic acid on a biologically active g-quadruplex. A structure-activity relationship of the thrombin aptamer. Int J Mol Sci 2008; 9: 422-433.
63. Kasahara Y, Kitadume S, Morihiro K, et al. Effect of 3'-end capping of aptamer with various 2',4'-bridged nucleotides: Enzymatic post-modification toward a practical use of polyclonal aptamers. Bioorg Med Chem Lett 2010; 20: 1626-1629.
64. Coppola T, Varra M, Oliviero G, et al. Synthesis, structural studies and biological properties of new TBA analogues containing an acyclic nucleotide. Bioorg Med Chem 2008; 16: 8244-8253.
65. Saneyoshi H, Mazzini S, Avino A, et al. Conformationally rigid nucleoside probes help understand the role of sugar pucker and nucleobase orientation in the thrombin-binding aptamer. Nucleic Acids Res 2009; 37: 5589-5601.
66. Tang CF, Shafer RH. Engineering the quadruplex fold: nucleoside conformation determines both folding topology and molecularity in guanine quadruplexes. J Am Chem Soc 2006; 128: 5966-5973.
67. Peng CG, Damha MJ. G-quadruplex induced stabilization by 2'-deoxy-2'-fluoro-D-arabinonucleic acids (2'F-ANA). Nucleic Acids Res 2007; 35: 4977-4988.
68. Marathias VM, Sawicki MJ, Bolton PH. 6-Thioguanine alters the structure and stability of duplex DNA and inhibits quadruplex DNA formation. Nucleic Acids Res 1999; 27: 2860-2867.
69. Nagatoishi S, Tanaka Y, Tsumoto K. Circular dichroism spectra demonstrate formation of the thrombin-binding DNA aptamer G-quadruplex under stabilizing-cation-deficient conditions. Biochem Biophys Res Commun 2007; 352: 812-817.
70. Webba da Silva M. Geometric formalism for DNA quadruplex folding. Chemistry 2007; 13: 9738-9745.
71. Wang Y, Patel DJ. Solution structure of a parallel-stranded G-quadruplex DNA. J Mol Biol 1993; 234: 1171-1183.
72. Jiang HL, Chen KX, Tang Y, et al. Binding conformers searching method for ligands according to the structures of their receptors and its application to thrombin inhibitors. Zhongguo Yao Li Xue Bao 1997; 18: 36-44.
73. Martino L, Virno A, Randazzo A, et al. A new modified thrombin binding aptamer containing a 5'-5' inversion of polarity site. Nucleic Acids Res 2006; 34: 6653-6662.
74. Russo Krauss I, Merlino A, Giancola C, Randazzo A, Mazzarella L, Sica F. Thrombin-aptamer recognition: a revealed ambiguity. Nucleic Acids Res 2011.
75. Liu CW, Huang CC, Chang HT. Highly selective DNA-based sensor for lead(II) and mercury(II) ions. Anal Chem 2009; 81: 2383-2387.
76. Choi MS, Yoon M, Baeg JO, Kim J. Label-free dual assay of DNA sequences and potassium ions using an aptamer probe and a molecular light switch complex. Chem Commun (Camb) 2009: 7419-7421.
77. Cai W, Fan Y, Jiang Z, Yao J. A highly sensitive and selective resonance scattering spectral assay for potassium ion based on aptamer and nanosilver aggregation reactions. Talanta 2010; 81: 1810-1815.
78. Smith FW, Feigon J. Strand orientation in the DNA quadruplex formed from the Oxytricha telomere repeat oligonucleotide d(G4T4G4) in solution. Biochemistry 1993; 32: 8682-8692.
79. Feigon J, Butcher SE, Finger LD, Hud NV. Solution nuclear magnetic resonance probing of cation binding sites on nucleic acids. Methods Enzymol 2001; 338: 400-420.
80. Hong ES, Yoon HJ, Kim B, Yim YH, So HY, Shin SK. Mass spectrometric studies of alkali metal ion binding on thrombin-binding aptamer DNA. J Am Soc Mass Spectrom 2010; 21: 1245-1255.
81. Marathias VM, Bolton PH. Determinants of DNA quadruplex structural type: sequence and potassium binding. Biochemistry 1999; 38: 4355-4364.
82. Wang KY, Gerena L, Swaminathan S, Bolton PH. Determination of the number and location of the manganese binding sites of DNA quadruplexes in solution by EPR and NMR. Nucleic Acids Res 1995; 23: 844-848.
83. Marathias VM, Wang KY, Kumar S, Pham TQ, Swaminathan S, Bolton PH. Determination of the number and location of the manganese binding sites of DNA quadruplexes in solution by EPR and NMR in the presence and absence of thrombin. J Mol Biol 1996; 260: 378-394.
84. Smirnov I, Shafer RH. Lead is unusually effective in sequence-specific folding of DNA. J Mol Biol 2000; 296: 1-5.
85. Smirnov IV, Kotch FW, Pickering IJ, Davis JT, Shafer RH. Pb EXAFS studies on DNA quadruplexes: identification of metal ion binding site. Biochemistry 2002; 41: 12133-12139.
86. Trajkovski M, Sket P, Plavec J. Cation localization and movement within DNA thrombin binding aptamer in solution. Org Biomol Chem 2009; 7: 4677-4684.
87. Kankia BI, Marky LA. Folding of the thrombin aptamer into a G-quadruplex with Sr(2+): stability, heat, and hydration. J Am Chem Soc 2001; 123: 10799-10804.
88. Schultze P, Hud NV, Smith FW, Feigon J. The effect of sodium, potassium and ammonium ions on the conformation of the dimeric quadruplex formed by the Oxytricha nova telomere repeat oligonucleotide d(G(4)T(4)G(4)). Nucleic Acids Res 1999; 27: 3018-3028.
89. Shim JW, Tan Q, Gu LQ. Single-molecule detection of folding and unfolding of the G-quadruplex aptamer in a nanopore nanocavity. Nucleic Acids Res 2009; 37: 972-982.
90. Vairamani M, Gross ML. G-quadruplex formation of thrombin-binding aptamer detected by electrospray ionization mass spectrometry. J Am Chem Soc 2003; 125: 42-43.
91. Tsiang M, Gibbs CS, Griffin LC, Dunn KE, Leung LL. Selection of a suppressor mutation that restores affinity of an oligonucleotide inhibitor for thrombin using in vitro genetics. J Biol Chem 1995; 270: 19370-19376.
92. Smirnov IV, Shafer RH. Electrostatics dominate quadruplex stability. Biopolymers 2007; 85: 91-101.
93. Bunka DH, Platonova O, Stockley PG. Development of aptamer therapeutics. Curr Opin Pharmacol 2010; 10: 557-562.
94. Buckheit RW, Jr., Roberson JL, Lackman-Smith C, Wyatt JR, Vickers TA, Ecker DJ. Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320). AIDS Res Hum Retroviruses 1994; 10: 1497-1506.
95. Koizumi M, Koga R, Hotoda H, et al. Biologically active oligodeoxyribonucleotides. Part 11: The least phosphate-modification of quadruplex-forming hexadeoxyribonucleotide TGGGAG, bearing 3-and 5-end-modification, with anti-HIV-1 activity. Bioorg Med Chem 1998; 6: 2469-2475.
96. Koizumi M, Koga R, Hotoda H, et al. Biologically active oligodeoxyribonucleotides--IX. Synthesis and anti-HIV-1 activity of hexadeoxyribonucleotides, TGGGAG, bearing 3'- and 5'-end-modification. Bioorg Med Chem 1997; 5: 2235-2243.
97. Zhou J, Swiderski P, Li H, Zhang J, Neff CP, Akkina R, Rossi JJ. Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells. Nucleic Acids Res 2009; 37: 3094-3109.
98. Mazumder A, Neamati N, Ojwang JO, Sunder S, Rando RF, Pommier Y. Inhibition of the human immunodeficiency virus type 1 integrase by guanosine quartet structures. Biochemistry 1996; 35: 13762-13771.
99. Jing N, Rando RF, Pommier Y, Hogan ME. Ion selective folding of loop domains in a potent anti-HIV oligonucleotide. Biochemistry 1997; 36: 12498-12505.
100. Jing N, Hogan ME. Structure-activity of tetrad-forming oligonucleotides as a potent anti-HIV therapeutic drug. J Biol Chem 1998; 273: 34992-34999.
101. de Soultrait VR, Lozach PY, Altmeyer R, Tarrago-Litvak L, Litvak S, Andreola ML. DNA aptamers derived from HIV-1 RNase H inhibitors are strong anti-integrase agents. J Mol Biol 2002; 324: 195-203.
102. Schneider DJ, Feigon J, Hostomsky Z, Gold L. High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus. Biochemistry 1995; 34: 9599-9610.
103. Somasunderam A, Ferguson MR, Rojo DR, et al. Combinatorial selection, inhibition, and antiviral activity of DNA thioaptamers targeting the RNase H domain of HIV-1 reverse transcriptase. Biochemistry 2005; 44: 10388-10395.
104. DeStefano JJ, Cristofaro JV. Selection of primer-template sequences that bind human immunodeficiency virus reverse transcriptase with high affinity. Nucleic Acids Res 2006; 34: 130-139.
105. DeStefano JJ, Nair GR. Novel aptamer inhibitors of human immunodeficiency virus reverse transcriptase. Oligonucleotides 2008; 18: 133-144.
106. Mosing RK, Mendonsa SD, Bowser MT. Capillary electrophoresis-SELEX selection of aptamers with affinity for HIV-1 reverse transcriptase. Anal Chem 2005; 77: 6107-6112.
107. Bellecave P, Andreola ML, Ventura M, Tarrago-Litvak L, Litvak S, Astier-Gin T. Selection of DNA aptamers that bind the RNA-dependent RNA polymerase of hepatitis C virus and inhibit viral RNA synthesis in vitro. Oligonucleotides 2003; 13: 455-463.
108. Bellecave P, Cazenave C, Rumi J, et al. Inhibition of hepatitis C virus (HCV) RNA polymerase by DNA aptamers: mechanism of inhibition of in vitro RNA synthesis and effect on HCV-infected cells. Antimicrob Agents Chemother 2008; 52: 2097-2110.
109. Qin L, Zheng R, Ma Z, et al. The selection and application of ssDNA aptamers against MPT64 protein in Mycobacterium tuberculosis. Clin Chem Lab Med 2009; 47: 405-411.
110. Becker RC, Povsic T, Cohen MG, Rusconi CP, Sullenger B. Nucleic acid aptamers as antithrombotic agents: Opportunities in extracellular therapeutics. Thromb Haemost 2010; 103: 586-595.
111. Muller J, Freitag D, Mayer G, Potzsch B. Anticoagulant characteristics of HD1-22, a bivalent aptamer that specifically inhibits thrombin and prothrombinase. J Thromb Haemost 2008; 6: 2105-2112.
112. Bates PJ, Laber DA, Miller DM, Thomas SD, Trent JO. Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer. Exp Mol Pathol 2009; 86: 151-164.
113. Girvan AC, Teng Y, Casson LK, Thomas SD, Juliger S, Ball MW, Klein JB, Pierce WM, Jr., Barve SS, Bates PJ. AGRO100 inhibits activation of nuclear factor-kappaB (NF-kappaB) by forming a complex with NF-kappaB essential modulator (NEMO) and nucleolin. Mol Cancer Ther 2006; 5: 1790-1799.
114. Shieh YA, Yang SJ, Wei MF, Shieh MJ. Aptamer-based tumor-targeted drug delivery for photodynamic therapy. ACS Nano 2010; 4: 1433-1442.
115. Jing N, Li Y, Xu X, et al. Targeting Stat3 with G-quartet oligodeoxynucleotides in human cancer cells. DNA Cell Biol 2003; 22: 685-696.
116. Teller C, Willner I. Functional nucleic acid nanostructures and DNA machines. Curr Opin Biotechnol 2010; 21: 376-391.
117. Li B, Dong S, Wang E. Homogeneous analysis: label-free and substrate-free aptasensors. Chem Asian J 2010; 5: 1262-1272.
118. Sassolas A, Blum LJ, Leca-Bouvier BD. Homogeneous assays using aptamers. Analyst 2011; 136: 257-274.
119. Travascio P, Bennet AJ, Wang DY, Sen D. A ribozyme and a catalytic DNA with peroxidase activity: active sites versus cofactor-binding sites. Chem Biol 1999; 6: 779-787.
120. Travascio P, Witting PK, Mauk AG, Sen D. The peroxidase activity of a hemin--DNA oligonucleotide complex: free radical damage to specific guanine bases of the DNA. J Am Chem Soc 2001; 123: 1337-1348.
121. Majhi PR, Shafer RH. Characterization of an unusual folding pattern in a catalytically active guanine quadruplex structure. Biopolymers 2006; 82: 558-569.
122. Bai L, Yuan R, Chai Y, Yuan Y, Zhuo Y, Mao L. Bi-enzyme functionlized hollow PtCo nanochains as labels for an electrochemical aptasensor. Biosens Bioelectron 2011; 26: 4331-4336.
123. Yuan Y, Gou X, Yuan R, et al. Electrochemical aptasensor based on the dual-amplification of G-quadruplex horseradish peroxidase-mimicking DNAzyme and blocking reagent-horseradish peroxidase. Biosens Bioelectron 2011; 26: 4236-4240.
124. Bi S, Li L, Zhang S. Triggered polycatenated DNA scaffolds for DNA sensors and aptasensors by a combination of rolling circle amplification and DNAzyme amplification. Anal Chem 2010; 82: 9447-9454.
125. Li T, Wang E, Dong S. G-quadruplex-based DNAzyme for facile colorimetric detection of thrombin. Chem Commun (Camb) 2008: 3654-3656.
126. Zhang Y, Li B, Jin Y. Label-free fluorescent detection of thrombin using G-quadruplex-based DNAzyme as sensing platform. Analyst 2011.
127. Yan S, Huang R, Zhou Y, et al. Aptamer-based turn-on fluorescent four-branched quaternary ammonium pyrazine probe for selective thrombin detection. Chem Commun (Camb) 2011; 47: 1273-1275.
128. Li Y, Bao J, Han M, Dai Z, Wang H. A simple assay to amplify the electrochemical signal by the aptamer based biosensor modified with CdS hollow nanospheres. Biosens Bioelectron 2011; 26: 3531-3535.
129. Zhang J, Chen P, Wu X, et al. A signal-on electrochemilumine-scence aptamer biosensor for the detection of ultratrace thrombin based on junction-probe. Biosens Bioelectron 2011; 26: 2645-2650.
130. Ochsenkuhn MA, Campbell CJ. Probing biomolecular interactions using surface enhanced Raman spectroscopy: label-free protein detection using a G-quadruplex DNA aptamer. Chem Commun (Camb) 2010; 46: 2799-2801.
131. Li T, Shi L, Wang E, Dong S. Multifunctional G-quadruplex aptamers and their application to protein detection. Chemistry 2009; 15: 1036-1042.
132. Vallon V, Muhlbauer B, Osswald H. Adenosine and kidney function. Physiol Rev 2006; 86: 901-940.
133. Mujoomdar M, Hoskin D, Blay J. Adenosine stimulation of the proliferation of colorectal carcinoma cell lines. Roles of cell density and adenosine metabolism. Biochem Pharmacol 2003; 66: 1737-1747.
134. Morita Y, Yoshida W, Savory N, et al. Development of a novel biosensing system based on the structural change of a polymerized guanine-quadruplex DNA nanostructure. Biosens Bioelectron 2011.
135. Wang J, Zhang P, Li JY, Chen LQ, Huang CZ, Li YF. Adenosine-aptamer recognition-induced assembly of gold nanorods and a highly sensitive plasmon resonance coupling assay of adenosine in the brain of model SD rat. Analyst 2010; 135: 2826-2831.
136. Chen SJ, Huang CC, Chang HT. Enrichment and fluorescence enhancement of adenosine using aptamer-gold nanoparticles, PDGF aptamer, and Oligreen. Talanta 2010; 81: 493-498.
137. Shlyahovsky B, Li Y, Lioubashevski O, Elbaz J, Willner I. Logic gates and antisense DNA devices operating on a translator nucleic Acid scaffold. ACS Nano 2009; 3: 1831-1843.
138. Liu F, Zhang J, Chen R, Chen L, Deng L. Highly effective colorimetric and visual detection of ATP by a DNAzyme-aptamer sensor. Chem Biodivers 2011; 8: 311-316.
139. Zhang JQ, Wang YS, He Y, et al. Determination of urinary adenosine using resonance light scattering of gold nanoparticles modified structure-switching aptamer. Anal Biochem 2010; 397: 212-217.
140. Zhang K, Zhu X, Wang J, Xu L, Li G. Strategy to fabricate an electrochemical aptasensor: application to the assay of adenosine deaminase activity. Anal Chem 2010; 82: 3207-3211.
141. Pelossof G, Tel-Vered R, Liu XQ, Willner I. Amplified Surface Plasmon Resonance-Based DNA Biosensors, Aptasensors, and Hg(2+) Sensors Using Hemin/G-Quadruplexes and Au Nanoparticles. Chemistry 2011.
142. Pelossof G, Tel-Vered R, Elbaz J, Willner I. Amplified biosensing using the horseradish peroxidase-mimicking DNAzyme as an electrocatalyst. Anal Chem 2010; 82: 4396-4402.
143. Deng M, Zhang D, Zhou Y, Zhou X. Highly effective colorimetric and visual detection of nucleic acids using an asymmetrically split peroxidase DNAzyme. J Am Chem Soc 2008; 130: 13095-13102.
144. Freeman R, Liu X, Willner I. Chemiluminescent and chemiluminescence resonance energy transfer (CRET) detection of DNA, metal ions, and aptamer-substrate complexes using hemin/G-quadruplexes and CdSe/ZnS quantum dots. J Am Chem Soc 2011; 133: 11597-11604.
145. Shi Y, Huang WT, Luo HQ, Li NB. A label-free DNA reduced graphene oxide-based fluorescent sensor for highly sensitive and selective detection of hemin. Chem Commun (Camb) 2011; 47: 4676-4678.
146. Yang C, Wang Y, Marty JL, Yang X. Aptamer-based colorimetric biosensing of Ochratoxin A using unmodified gold nanoparticles indicator. Biosens Bioelectron 2011; 26: 2724-2727.
147. Li T, Wang E, Dong S. Lead(II)-induced allosteric G-quadruplex DNAzyme as a colorimetric and chemiluminescence sensor for highly sensitive and selective Pb2+ detection. Anal Chem 2010; 82: 1515-1520.
148. Thiel K. Oligo oligarchy-the surprisingly small world of aptamers. Nat Biotechnol 2004; 22: 649-651.
149. Missailidis S, Hardy A. Aptamers as inhibitors of target proteins. Expert Opin Ther Pat 2009; 19: 1073-1082.